(Re-casts with analyst comments) By Maggie Fick and Aby Jose Koilparambil March 24 (Reuters) - A California judge's decision to allow expert testimony linking GSK's heartburn drug Zantac to cancer
(Adds reactions, details on planned visit) By Benoit Van Overstraeten and Elizabeth Pineau PARIS, March 24 (Reuters) - Britain's King Charles on Friday cancelled a state visit to France after social
(Adds reaction) By Huw Jones LONDON, March 24 (Reuters) - Rules inherited from the European Union that crack down on abuses in financial markets need updating to ensure regulators can tackle breaches,
(Adds comment from former corporate investigator) By Michael Martina and Yew Lun Tian WASHINGTON/BEIJING, March 24 (Reuters) - Chinese authorities raided the office of U.S. corporate due diligence
PARIS (Reuters) - The state visit of King Charles to France will be postponed amid tensions over pension reform, the French Presidency said on Friday. The French and British governments took the
(Adds shares down) March 24 (Reuters) - GSK Plc said on Friday it "respectfully disagrees" with a ruling by a California state court in litigation related to claims that the company's heartburn drug,
March 24 (Reuters) - GSK Plc said on Friday it "respectfully disagrees" with a ruling by the California state court in a litigation related to claims that the pharmaceutical major's heartburn drug,
By Dominique Vidalon PARIS (Reuters) - France said it was ready to host Britain's King Charles on a state visit from Sunday despite unrest over changes to the pension system erupting into violence in
(Adds detail) LONDON, March 24 (Reuters) - Rules inherited from the European Union that crack down on abuses in financial markets need updating to ensure regulators can act properly against breaches,
March 24 (Reuters) - GSK plc: * GSK PLC - STATEMENT: ZANTAC (RANITIDINE) LITIGATION * GSK - GSK RESPECTFULLY DISAGREES WITH SARGON RULING BY CALIFORNIA STATE COURT IN RESPECT OF GOETZ CASE * GSK, ON